Search Results - Jeremy A. W. Gold

Low utilization of confirmatory testing for tinea capitis by pediatricians at an academic center in New York, United States, 2005-2021 by Jonathan K. Hwang, Jeremy A. W. Gold, Amy S. Paller, Shari R. Lipner

Connect to this object online.

Low positivity rate and high percentage of nondermatophyte molds in an analysis of 35,257 fungal nail culture results from a United States national commercial laboratory, 2019-2022 by Kaitlin Benedict, MPH, Shari R. Lipner, MD, PhD, Shawn R. Lockhart, PhD, Jeremy A.W. Gold, MD

Connect to this object online.

Prescribing of clotrimazole-betamethasone dipropionate, a topical combination corticosteroid-antifungal product, for Medicare part D beneficiaries, United States, 2016-2022 by Dustin W. Currie, Avrom S. Caplan, Kaitlin Benedict, Kelly M. Hatfield, Dallas J. Smith, Shari R. Lipner, Jeremy A.W. Gold

Connect to this object online.

Improving antifungal stewardship in dermatology in an era of emerging dermatophyte resistance by Avrom S. Caplan, MD, Jeremy A.W. Gold, MD, MS, Dallas J. Smith, PharmD, MAS, Shari R. Lipner, MD, PhD, Peter G. Pappas, MD, Boni Elewski, MD

Connect to this object online.